ELIZABETH DONG NGUYEN
Medical Practice at Sand Point Way, Seattle, WA
License number
Washington ML60561467
Category
Medical Practice
Type
Pediatrics
Address
Address
4800 Sand Point Way NE OC.7.830, Seattle, WA 98105
Phone
(206) 987-2525
Personal information
See more information about ELIZABETH DONG NGUYEN at radaris.comName
Address
Phone
5312 S Hazel St, Seattle, WA 98178
9104 211Th Street Ct E, Graham, WA 98338
1908 Walker St, Seattle, WA 98144
18100 142Nd Ave NE, Woodinville, WA 98072
14211 7Th Way, Vancouver, WA 98683
Professional information
See more information about ELIZABETH DONG NGUYEN at trustoria.com
Accountant At Pemco Technology Services Inc.,
Accountant At Pemco Technology Services Inc.,
Position:
Accountant at Pemco Technology Services Inc.,
Location:
Greater Seattle Area
Industry:
Accounting
Work:
Pemco Technology Services Inc.,
-
Accountant
Education:
DePaul University 1987 - 1991
Independent Banking Professional
Independent Banking Professional
Location:
Greater Seattle Area
Industry:
Banking
Contract Specialist At Western Regional Medical Command
Contract Specialist At Western Regional Medical Command
Position:
contract specialist at western regional medical command
Location:
Greater Seattle Area
Industry:
Defense & Space
Work:
western regional medical command
-
contract specialist
Methods Of Isolating Amyloid-Inhibiting Compounds And Use Of Compounds Isolated From Uncaria Tomentosa And Related Plants
Methods Of Isolating Amyloid-Inhibiting Compounds And Use Of Compounds Isolated From Uncaria Tomentosa And Related Plants
US Patent:
6929808, Aug 16, 2005
Filed:
Nov 2, 2001
Appl. No.:
10/053625
Inventors:
Gerardo Castillo - Seattle WA, US
Paula Y. Choi - Bothell WA, US
Elizabeth Nguyen - Renton WA, US
Alan D. Snow - Lynnwood WA, US
Paula Y. Choi - Bothell WA, US
Elizabeth Nguyen - Renton WA, US
Alan D. Snow - Lynnwood WA, US
Assignee:
ProteoTech, Inc. - Kirkland WA
International Classification:
A51K035/78, A61K031/35
US Classification:
424725, 424769, 514456
Abstract:
Assay-guided affinity fractionation and reverse phase high pressure liquid chromatography (HPLC) methodology to isolate, test and characterize the most active water-soluble ingredients within Cat's Claw, or. These components appear to account for the majority of the amyloid or Aβ fibrillogenesis inhibitory activity. Individual fractions and/or compounds as isolated by HPLC are tested in relevant in vitro and/or animal models, and found to consistently demonstrate inhibition of amyloid or Aβ fibrillogenesis. Related extraction methods are disclosed.